Streetbeat News

Products Services

OCX

Oncocyte Corporation's (NASDAQ:OCX) VitaGraft Kidney diagnostic test has received a positive coverage decision from Palmetto GBA, the Medicare Administrative Contractor for the Centers for Medicare & Medicaid Services (CMS). The test is designed to identify signs of graft damage in kidney transplant patients. Initial revenue from the service lab business is expected to begin in Q1 2024. Oncocyte's second transplant test, VitaGraft Liver, remains under review for coverage at MolDX.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:34 pm

ANIX

Anixa Biosciences has announced the treatment of the third patient in its ovarian cancer CAR-T clinical trial. This marks a significant step in the company's ongoing research and development efforts in the field of cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:33 pm

NBIX

Neurocrine Biosciences has presented new data on its INGREZZA capsules at the 2023 MDS International Congress of Parkinson's Disease and Movement Disorders. The data shows early and sustained improvements in chorea associated with Huntington's disease.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:32 pm

DGLY

Digital Ally, Inc. (NASDAQ:DGLY) has received an order for 40 FirstVu Pro body-worn cameras and five 8-bay QuickVu docking stations from the South Carolina Ports Authority Police Guard. The order was placed through the company's subscription payment plan. This follows several similar orders and patents, demonstrating the company's commitment to innovation and a world-class video solutions ecosystem.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:31 pm

IMGN

TAK

ImmunoGen (NASDAQ:IMGN) has signed an agreement with Takeda Pharmaceutical (NYSE:TAK) to develop and commercialize the ovarian cancer drug ELAHERE in Japan. ImmunoGen will receive $34 million in upfront and near-term milestone payments and is also eligible for potential regulatory and commercial milestone payments. ImmunoGen retains exclusive production rights and will supply the product for development and commercial use in Japan, while Takeda will receive an exclusive license to develop and commercialize ELAHERE in Japan.

Portfolio Pulse from Nabaparna Bhattacharya

August 28, 2023 | 12:22 pm

BSX

Boston Scientific's FARAPULSE treatment for atrial fibrillation has met its primary endpoints, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:22 pm

NVS

Novartis has presented new long-term data for Leqvio, demonstrating consistent efficacy and safety beyond six years. This could potentially boost the company's reputation and sales in the long run.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:16 pm

DATS

DatChat (NASDAQ:DATS) has signed a marketing Memorandum of Understanding with Cloud Water Brands to promote their products within the Habytat Virtual World. The partnership will involve product placements, Interactive 3D displays and NPC advertising. Habytat has also launched its Brand Marketing Partnership Program, making the platform accessible to companies wishing to engage new audiences within the metaverse.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:13 pm

UCL

Ucloudlink Group has begun commercializing its Internet of Things (IoT) solutions, partnering with Maya Net Solution and NTT Media Supply Co., Ltd., a subsidiary of Japan's Nippon Telegraph and Telephone Corporation.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 12:12 pm

GDC

GD Culture Group Limited (GDC) has announced the launch of a live-streaming e-commerce business on TikTok via its subsidiaries Shanghai Highlight Media Co., Ltd. and AI Catalysis Corp. The move aims to capitalize on TikTok's growing user base and revenue, which reached $9.4 billion in 2022, a 100% YoY increase. GDC's initiative is expected to redefine the online shopping experience by offering curated products and real-time interaction.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 12:10 pm